Updates

Innovaderma

October 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Innovaderma’s results to end June showed sales up 105% to £8.6m and pretax profit up five-fold to £1m for eps of 4.7p. It’s been a busy year with the company relocating production of Skinny Tan to the UK (helping gross margins lift 5.6% to 63%) and widening the product range. It also made three small acquisitions, opening up nascent opportunities in new categories.The swing factor was Skinny Tan, whose brand appeal has seen it attract more than 300,000 followers on its social media platforms, helping to drive retailer representation - Innovaderma’s Direct-to-Consumer strategy. The brand became the No.1 selling brand in Superdrug by revenue in its category with 10 new products added. Post the period end ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Quantum Pharma - Gain since our February write up: 75%

Filta Group

InnovaDerma (October 2018)

InnovaDerma (June 2018)

InnovaDerma - Soon-to-be prospective PE of 10.6 (March 2018)

Innovaderma - Shares look unduly depressed (December 2017)

Innovaderma (November 2017)

Innovaderma - Broker calls up shares to 600p (July 2017)

Innovaderma (June 2017)

Innovaderma - All time record quarter (May 2017)

Innovaderma - Beauty of the internet age (March 2017)

Innovaderma (February 2017)

Innovaderma - An enigma (January 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X